MELINDA MOSBY: Open Payments
NPI 1548445562 · JACKSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,277 in 28 payments from 8 companies in 2025. Trend: 2023 $1,047 · 2024 $5,642 · 2025 $5,277
Speaker / faculty: $4,643Food & beverage: $634
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $4,915 |
| Lundbeck LLC | 3 | $85 |
| Alkermes, Inc. | 3 | $79 |
| Vanda Pharmaceuticals Inc. | 3 | $74 |
| Janssen Pharmaceuticals, Inc | 4 | $70 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: UZEDY, ARISTADA, ABILIFY ASIMTUFII, INVEGA SUSTENNA, FANAPT, REXULTI, HETLIOZ, Qelbree.
Industry payments across TN — which companies pay providers there.
